Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Brain Res

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    February 2017
  1. NAVIGATORE-FONZO L, Castro A, Pignataro V, Casais M, et al
    Daily rhythms of cognition-related factors are modified in an experimental model of alzheimer disease.
    Brain Res. 2017 Feb 2. pii: S0006-8993(17)30046.
    PubMed     Text format     Abstract available


    January 2017
  2. FANG X, Zhong X, Yu G, Shao S, et al
    Vascular protective effects of KLF2 on Abeta-induced toxicity: Implications for Alzheimer's disease.
    Brain Res. 2017 Jan 24. pii: S0006-8993(17)30006.
    PubMed     Text format     Abstract available


    November 2016
  3. DUAN H, Jiang J, Xu J, Zhou H, et al
    Differences in Abeta brain networks in Alzheimer's disease and healthy controls.
    Brain Res. 2016 Nov 17. pii: S0006-8993(16)30775.
    PubMed     Text format     Abstract available


  4. TENTOLOURIS-PIPERAS V, Ryan NS, Thomas DL, Kinnunen KM, et al
    Brain imaging evidence of early involvement of subcortical regions in familial and sporadic Alzheimer's disease.
    Brain Res. 2016 Nov 12. pii: S0006-8993(16)30751.
    PubMed     Text format     Abstract available


    September 2016
  5. PADAYACHEE E, Zetterberg H, Portelius E, Boren J, et al
    Cerebrospinal fluid-induced retardation of amyloid beta aggregation correlates with Alzheimer's disease and the APOE epsilon4 allele.
    Brain Res. 2016 Sep 18. pii: S0006-8993(16)30651.
    PubMed     Text format     Abstract available


  6. ZHUANG S, Wang X, Wang HF, Li J, et al
    Angiotensin Converting Enzyme Serum Activities: Relationship with Alzheimer's disease.
    Brain Res. 2016 Sep 5. pii: S0006-8993(16)30611.
    PubMed     Text format     Abstract available


    July 2016
  7. PAPADANIIL CD, Kosmidou VE, Tsolaki A, Tsolaki M, et al
    Cognitive MMN and P300 in Mild Cognitive Impairment and Alzheimer's Disease: A High Density EEG-3D Vector Field Tomography Approach.
    Brain Res. 2016 Jul 30. pii: S0006-8993(16)30534.
    PubMed     Text format     Abstract available


    June 2016
  8. LEE JK, Wang K, Park MH, Kim N, et al
    Probing amyloid beta-induced cell death using a fluorescence-peptide conjugate in Alzheimer's disease mouse model.
    Brain Res. 2016 Jun 29. pii: S0006-8993(16)30465.
    PubMed     Text format     Abstract available


  9. YAN H, Zhu X, Xie J, Zhao Y, et al
    beta-amyloid increases neurocan expression through regulating Sox9 in astrocytes: a potential relationship between Sox9 and chondroitin sulfate proteoglycans in Alzheimer's disease.
    Brain Res. 2016 Jun 15. pii: S0006-8993(16)30434.
    PubMed     Text format     Abstract available


    May 2016
  10. SARKAR S, Jun S, Rellick S, Quintana DD, et al
    Expression of MicroRNA-34a in Alzheimer's Disease Brain Targets Genes Linked to Synaptic Plasticity, Energy Metabolism, and Resting State Network Activity.
    Brain Res. 2016 May 25. pii: S0006-8993(16)30382.
    PubMed     Text format     Abstract available


  11. DEIBEL SH, Weishaupt N, Regis AM, Hong NS, et al
    Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and beta-amyloid.
    Brain Res. 2016 May 18. pii: S0006-8993(16)30388.
    PubMed     Text format     Abstract available


    April 2016
  12. JAYANT S, Sharma BM, Sharma B
    Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease.
    Brain Res. 2016 Apr 12. pii: S0006-8993(16)30230.
    PubMed     Text format     Abstract available


  13. LI J, Liu CN, Wei N, Li XD, et al
    Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-beta peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease.
    Brain Res. 2016 Apr 9. pii: S0006-8993(16)30204.
    PubMed     Text format     Abstract available


    March 2016
  14. YOON SY, Kim DH
    Alzheimer's disease genes and autophagy.
    Brain Res. 2016 Mar 22. pii: S0006-8993(16)30147.
    PubMed     Text format     Abstract available


  15. WANG J, Li N, Ma J, Gu Z, et al
    Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice.
    Brain Res. 2016;1635:169-79.
    PubMed     Text format     Abstract available


  16. PALLO SP, DiMaio J, Cook A, Nilsson B, et al
    Mechanisms of tau and Abeta-induced excitotoxicity.
    Brain Res. 2016;1634:119-31.
    PubMed     Text format     Abstract available


    February 2016
  17. HAYAMA T, Murakami K, Watanabe T, Maeda R, et al
    Single administration of a novel gamma-secretase modulator ameliorates cognitive dysfunction in aged C57BL/6J mice.
    Brain Res. 2016;1633:52-61.
    PubMed     Text format     Abstract available


  18. ZOU J, Wang M, Uchiumi O, Shui Y, et al
    Learning impairment by minimal cortical injury in a mouse model of Alzheimer's disease.
    Brain Res. 2016 Feb 11. pii: S0006-8993(16)30060.
    PubMed     Text format     Abstract available


    January 2016
  19. LIU C, Wu Y, Zha S, Liu M, et al
    Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Brain Res. 2016;1631:137-46.
    PubMed     Text format     Abstract available


    December 2015
  20. MURAKAMI K, Watanabe T, Koike T, Kamata M, et al
    Pharmacological properties of a novel and potent gamma-secretase modulator as a therapeutic option for the treatment of Alzheimer's disease.
    Brain Res. 2015 Dec 17. pii: S0006-8993(15)00955.
    PubMed     Text format     Abstract available


    October 2015
  21. SULLIVAN SE, Young-Pearse T
    Induced pluripotent stem cells as a discovery tool for Alzheimer's disease.
    Brain Res. 2015 Oct 9. pii: S0006-8993(15)00742.
    PubMed     Text format     Abstract available


    September 2015
  22. SHETTY AK, Bates A
    Potential of GABA-ergic Cell Therapy for Schizophrenia, Neuropathic Pain, and Alzheimer's and Parkinson's Diseases.
    Brain Res. 2015 Sep 27. pii: S0006-8993(15)00717.
    PubMed     Text format     Abstract available


    August 2015
  23. DOTY KR, Guillot-Sestier MV, Town T
    The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Brain Res. 2015;1617:155-73.
    PubMed     Text format     Abstract available


  24. GREEN DL, Payne L, Polikar R, Moberg PJ, et al
    P50: A candidate ERP biomarker of prodromal Alzheimer's disease.
    Brain Res. 2015 Aug 6. pii: S0006-8993(15)00599.
    PubMed     Text format     Abstract available


    July 2015
  25. OLIVEIRA LT, Leon GV, Provance DW Jr, de Mello FG, et al
    Exogenous beta-amyloid peptide interferes with GLUT4 localization in neurons.
    Brain Res. 2015;1615:42-50.
    PubMed     Text format     Abstract available


  26. ZONG Y, Yu P, Cheng H, Wang H, et al
    miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer's disease.
    Brain Res. 2015 Jul 23. pii: S0006-8993(15)00551.
    PubMed     Text format     Abstract available


  27. HOSONO T, Nishitsuji K, Nakamura T, Jung CG, et al
    Arachidonic acid diet attenuates brain Abeta deposition in Tg2576 mice.
    Brain Res. 2015;1613:92-9.
    PubMed     Text format     Abstract available


    June 2015
  28. ALTOBELLI GG, Cimini D, Esposito G, Iuvone T, et al
    Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection.
    Brain Res. 2015;1610:89-97.
    PubMed     Text format     Abstract available


  29. LI YP, Yang GJ, Jin L, Yang HM, et al
    Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid beta in mice.
    Brain Res. 2015 Jun 4. pii: S0006-8993(15)00447.
    PubMed     Text format     Abstract available


    May 2015
  30. JANOTA CS, Brites D, Lemere CA, Brito MA, et al
    Glio-vascular changes during ageing in wild-type and in Alzheimer's disease-like APP/PS1 mice.
    Brain Res. 2015 May 9. pii: S0006-8993(15)00370.
    PubMed     Text format     Abstract available


    February 2015
  31. KANAMARU T, Kamimura N, Yokota T, Nishimaki K, et al
    Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease.
    Brain Res. 2015 Feb 16. pii: S0006-8993(15)00111.
    PubMed     Text format     Abstract available


    January 2015
  32. CANDELA P, Saint-Pol J, Kuntz M, Boucau MC, et al
    In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
    Brain Res. 2015;1594:15-26.
    PubMed     Text format     Abstract available


    December 2014
  33. CHAE YJ, Lee HJ, Jeon JH, Kim IB, et al
    Effects of donepezil on hERG potassium channels.
    Brain Res. 2014 Dec 8. pii: S0006-8993(14)01664.
    PubMed     Text format     Abstract available


    November 2014
  34. BI OH S, Suh N, Kim I, Lee JY, et al
    Impacts of aging and amyloid-beta deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Brain Res. 2014 Nov 29. pii: S0006-8993(14)01626.
    PubMed     Text format     Abstract available


  35. TIAN M, Deng YY, Hou DR, Li W, et al
    Association of IL-1, IL-18, and IL-33 gene polymorphisms with late-onset Alzheimers disease in a Hunan Han Chinese population.
    Brain Res. 2014 Nov 20. pii: S0006-8993(14)01566.
    PubMed     Text format     Abstract available


    May 2014
  36. ZHANG ZH, Yu LJ, Hui XC, Wu ZZ, et al
    Hydroxy-safflor yellow A attenuates Abeta(1)(-)(4)(2)-induced inflammation by modulating the JAK2/STAT3/NF-kappaB pathway.
    Brain Res. 2014;1563:72-80.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: